Jeff Stoll

Jeff serves as the National Leader of Life Sciences for the Strategy practice. He has 20 years of experience providing strategy consulting services to the biopharmaceutical industry and private equity clients interested in the life science sector. He specializes in supporting clients across the inorganic growth continuum from growth strategy to portfolio optimization to commercial due diligence to integration and divestiture strategy. Jeff and his team have averaged thirty deals per year between strategic and private equity clients for the past ten years. Prior to starting his consulting career, Jeff was an Assistant Professor at the University of Florida with an appointment at Shands Hospital, where he specialized in solid organ transplant.